Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray after gynecologic endoscopic surgery
ChiCTR2400080181Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in sleep disorder (2 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoints: Sleep Assessment Scale, Deep sleep duration and 2 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2400080181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080181.